Czechia, Feb. 13 -- Czechia based Gilead Sciences s.r.o. has secured contract from Fakultni nemocnice Ostrava for Antineoplastic and immunomodulating agents - DODAVKA YESCARTA. The value of the contract is worth 664284820 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....